Filter
1144
Filtered Results: 1144
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
110
New Publications
283
Language
Document type
No document type
517
Studies & Reports
241
Guidelines
197
Manuals
80
Strategic & Response Plan
60
Fact sheets
20
Training Material
14
Situation Updates
8
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
53
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
28
Nigeria
25
Ghana
18
South Africa
18
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Rwanda
12
Africa
12
Tanzania
12
Eastern Europe
12
Zambia
12
Latin America and the Carribbean
11
South–East Asia Region
10
Namibia
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
China
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Vietnam
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
382
Clinical Guidelines
107
Public Health
68
Key Resources
59
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
8
Toolboxes
AMR
137
Pharmacy
133
COVID-19
81
TB
57
Mental Health
55
HIV
53
Rapid Response
48
NTDs
33
Planetary Health
27
Caregiver
26
Global Health Education
25
NCDs
22
Conflict
22
Health Financing Toolbox
20
Specific Hazards
12
Ebola & Marburg
10
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio...
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Southern Med Review (2009)2;1:2-6
Fair global distribution of COVID-19 vaccines
recommended
MEDBOX Issue Brief no.9 ,1 Febr. 2021
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
Lessons from the STEP-TB Project.
Accessed November 2017.
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
PMPB/INS-GUIDE/02
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV ...
